binx health brings to market the first ever FDA-cleared, CLIA-waived point-of-care test for chlamydia and gonorrhea for male and female patients that provides central lab performance results in about thirty minutes. With the binx io, patients can test, receive a diagnosis, and access treatment all in a single visit, eliminating unnecessary visits and delays.